Dr. Christian Kannemeier

Senior Investment Manager

Dr. Christian Kannemeier

Senior Investment Manager

Christian joined HTGF’s Life Science team as a Senior Investment Manager in August 2023. Christian studied biology in Giessen and received his PhD in cell biology/biochemistry in collaboration with a pharmaceutical company in Marburg. Subsequently, he did postdoctoral research at the Scripps Research Institute in San Diego in the field of tumor transformation.

During his 11-year tenure with two start-up companies in California and Wisconsin, Christian led projects on the generation, differentiation, and application of human stem cells in various disease models in the drug discovery process. He has led projects on high throughput human stem cell manufacturing and the introduction of new cell-based products.

In 2018, he moved to Evotec in Hamburg, Germany, where he was able to further advance the application of stem cells in drug discovery and learn about the drug discovery processes in detail.

Posts & mentions

Press
1. February 2024

Fresh Growth Capital: Innerspace secures € 5.7 Million for Further Expansion to the USA

Financing round secures Tyrolean start-up €5.7 million for continued growth   Cooperation agreement with global industry association “PDA”  Innsbruck, 1 February 2024. The Innsbruck-based tech start-up Innerspace, which enables risk assessment of production processes and effective training of cleanroom personnel for leading pharmaceutical companies using software and Virtual Reality (VR), can advance its growth trajectory after a highly succes